1-[4-[3-[4-(1H-benzimidazole-2-carbonyl)phenoxy]pyrazin-2-yl]piperidin-1-yl]ethanone manufacturers
- AMG 579
-
- $30.00 / 1mg
-
2025-11-10
- CAS:1227067-61-9
- Min. Order:
- Purity: 99.87%
- Supply Ability: 10g
- AMG 579
-
- $30.00 / 1mg
-
2025-11-10
- CAS:1227067-61-9
- Min. Order:
- Purity: 99.87%
- Supply Ability: 10g
|
| | 1-[4-[3-[4-(1H-benzimidazole-2-carbonyl)phenoxy]pyrazin-2-yl]piperidin-1-yl]ethanone Basic information |
| | 1-[4-[3-[4-(1H-benzimidazole-2-carbonyl)phenoxy]pyrazin-2-yl]piperidin-1-yl]ethanone Chemical Properties |
| Boiling point | 689.9±65.0 °C(Predicted) | | density | 1.322±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO: 41.67 mg/mL (94.39 mM) | | pka | 10.10±0.10(Predicted) | | form | Solid | | color | Off-white to light yellow |
| | 1-[4-[3-[4-(1H-benzimidazole-2-carbonyl)phenoxy]pyrazin-2-yl]piperidin-1-yl]ethanone Usage And Synthesis |
| Uses | AMG 579 is a potent, selective, and efficacious inhibitor of phosphodiesterase 10A (PDE10A) with an IC50 of 0.1 nM. | | in vivo | AMG 579 shows statistically significant reduction of PCP induced behavior in rats over the 2 h period. Minimum effective doses for efficacy in PCP-LMA model is determined to be 0.3 mg/kg for AMG 579. In dog, 5 exhibits superior oral bioavailability of 72%[1]. | | References | [1] Hu E,et al. Discovery of clinical candidate 1-(4-(3-(4-(1H-benzo[d]imidazole-2-carbonyl)phenoxy)pyrazin-2-yl)piperidin-1-yl)ethanone (AMG 579), a potent, selective, and efficacious inhibitor of phosphodiesterase 10A (PDE10A). J Med Chem. 2014 Aug 14;57(15 DOI:10.1021/jm500713j |
| | 1-[4-[3-[4-(1H-benzimidazole-2-carbonyl)phenoxy]pyrazin-2-yl]piperidin-1-yl]ethanone Preparation Products And Raw materials |
|